Details of the Drug

General Information of Drug (ID: DMBOCAF)

Drug Name

ECT-001

Indication

Disease Entry	ICD 11	Status	REF
Hematologic tumour	2B33.Y	Phase 2	[1]
------------------------------------------------------------------------------------

Drug Type

Cell therapy

Cross-matching ID

References

1	ClinicalTrials.gov (NCT04103879) US Study of UM171-Expanded CB in Patients With High Risk Leukemia/Myelodysplasia. U.S. National Institutes of Health.